Use of non-conventional medicine two years after cancer diagnosis in France: evidence from the VICAN survey-Reference-Cited by-同舟云学术

Use of non-conventional medicine two years after cancer diagnosis in France: evidence from the VICAN survey

Published:2017-02-01 Issue:4 Volume:11 Page:421-430
ISSN:1932-2259
Container-title:Journal of Cancer Survivorship
language:en
Short-container-title:J Cancer Surviv

Author:

Sarradon-Eck Aline,Bouhnik Anne-Déborah,Rey Dominique,Bendiane Marc-Karim,Huiart Laetitia,Peretti-Watel Patrick

Funder

National Institute of Cancer

Publisher

Springer Science and Business Media LLC

Subject

Oncology(nursing),Oncology

Link

http://link.springer.com/article/10.1007/s11764-017-0599-y/fulltext.html

Reference71 articles.

1. National Center for Complementary and Alternative Medicine. Expanding horizons of healthcare: five-year strategic plan 2001–2005. U.S. Department of Health and Human Services and National Institutes of Health, Editor. 2000.

2. National Center for Complementary and Integrative Health. https://nccih.nih.gov/health/integrative-health#types . Accessed 10 Jan 2017.

3. Horneber M, Bueschel G, Less D, et al. How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integr Cancer Ther. 2012;11(3):187–203.

4. Adler SR. Complementary and alternative medicine use among women with breast cancer. Med Anthropol Q. 1999;13(2):214–22.

5. Ganz PA, Desmond KA, Leedham B, et al. Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J Natl Cancer Inst. 2002;94(1):39–49.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Socio-demographic and health-related determinants of patients’ overall rating and experiences of cancer care;BMC Cancer;2023-09-29

2. Quality of life in older French long-term lung cancer survivors: VICAN5 national survey;Lung Cancer;2023-06

3. Benefits of Homeopathic Complementary Treatment in Patients With Breast Cancer: A Retrospective Cohort Study Based on the French Nationwide Healthcare Database;Clinical Breast Cancer;2023-01

4. Out-of-Pocket Costs of Complementary Medicine Following Cancer and the Financial Impact in a Setting With Universal Health Coverage: Findings From a Prospective Cohort Study;JCO Oncology Practice;2021-10

5. Prevalence of drug–drug interactions in sarcoma patients: key role of the pharmacist integration for toxicity risk management;Cancer Chemotherapy and Pharmacology;2021-07-24